Cardiac troponin I and T are well known as biomarkers in the assessment of myocardial injury. An appreciation and understanding the pathophysiology of troponin and the timing of troponin testing is fundamental in the clinical utility of these biomarkers, as troponin and its kinetics are central to the universal definition of acute myocardial infarction (AMI).
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.